The antiviral agent 5-chloro-1, 3-dihydroxyacridone interferes with assembly and maturation of herpes simplex virus

Antiviral Research

Volumn 53, Issue 2, 2002, Pages 113-126

  Akanitapichat, P ^a,b   Bastow, K F ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Faculty of Science   (Thailand)

Author keywords

Acridone; Antiviral; Viral assembly

Indexed keywords

5 CHLORO 1,3 DIHYDROXYACRIDONE; ACRIDONE DERIVATIVE; ANTIVIRUS AGENT; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CLEAVAGE; DNA PACKAGING; DNA REPLICATION; DRUG EFFECT; DRUG MECHANISM; HERPES SIMPLEX VIRUS; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS ISOLATION; VIRUS MORPHOGENESIS; VIRUS MUTANT;

ACRIDINES; ANIMALS; ANTIVIRAL AGENTS; CAPSID; CERCOPITHECUS AETHIOPS; DNA, VIRAL; HERPES SIMPLEX; HUMANS; SIMPLEXVIRUS; VERO CELLS; VIRUS ASSEMBLY; VIRUS REPLICATION;

SIMPLEXVIRUS;

EID: 0036144084     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(01)00203-0     Document Type: Article

References (39)

1. Characterization of a herpes simplex virus type 1 mutant which has a temperature sensitive defect in penetration of cells and assembly of capsids
2. Herpes simplex type 1 UL28 gene product is important for the formation of mature capsids
3. 1, 3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication
4. The herpes simplex virus UL33 gene product is required for the assembly of full capsids
5. The UL15 gene of herpes simplex type 1 contains within its second exon a novel open reading frame that is translated in frame with the UL15 gene product
6. Synthesis of dihydrofolate reductase and metabolism of related RNA in a methotrexate resistant human cell line infected with herpes simplex virus type 2
7. Antiproliferative actions of 7-substituted 1, 3-dihydroxyacridones; possible involvement of DNA topoisomerase II and protein kinase C as biochemical targets
8. Synthesis and evaluation of camptothecin-4-β-amino-epipodophyllotoxin conjugates as inhibitors of mammalian DNA topoisomerases and of cell growth
9. Antiviral agents, DNA
10. Antiviral activity of methylated nordihydrogualaretic acids. 2. Targeting herpes simplex virus replication by the mutation-insensitive transcription inhibitor tetra-O-methyl NDGA
11. ATP depletion blocks herpes simplex virus DNA packaging and capsid maturation
12. Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA
13. The size and symmetry of B capsids of herpes simplex virus type I are determined by the gene products of the UL26 open reading frame
14. The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth
15. Proteins specified by herpes simplex virus: VIII. Characterization and composition of multiple capsid forms of subtypes 1 and 2
16. Capsid assembly and DNA packaging in herpes simplex virus
17. Rapid small-scale isolation of herpes simplex virus DNA
18. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
19. The herpes simplex type 1 cleavage/packaging protein, UL32, is involved in efficient localization of capsids to replication compartments
20. Intracellular organization of herpes simplex virus type 1 DNA assayed by staphylococcal nuclease sensitivity
21. Herpes simplex type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates
22. The product of the herpes simplex type 1 UL25 gene is required for encapsidation but not for cleavage of replicated viral DNA
23. Silver staining methods for polyacrylamide gel electrophoresis
24. Rapid small-scale isolation of SV40 virions and SV40 DNA
25. Capsids are formed in a mutant virus blocked at the maturation site of the UL26 and UL26.5 open reading frames of herpes simplex type I but are not formed in a null mutant of UL38 (VP19c)
26. Identification and characterization of a herpes simplex virus gene product required for encapsidation of viral DNA
27. Alterations in catalytic activity and virus maturation produced by mutation of the conserved histidine residues of herpes simplex virus type 1 protease
28. Structure and assembly of herpesviruses
29. Herpes simplex viruses and their replication
30. Ultrastructure of Leydig cells as revealed by secondary tissue treatment with a ferrocyanide: Osmium mixture
31. The herpes simplex type 1 UL17 gene encodes virion tegument proteins that are required for cleavage and packaging of viral DNA
32. DNA processing in temperature-sensitive morphogenic mutants of HSV 1
33. Characterization of intranuclear capsids made by ts morphogenic mutants of HSV 1
34. The herpes simplex virus procapsid: Structure, conformational changes upon maturation, and roles of the triplex proteins VP19c and VP23 in assembly
35. Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1, 3-dihydroxyacridone and 1, 3, 7-trihydroxyacridone
36. Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: Resistance maps to the UL6 gene
37. Assemblons: Nuclear structures defined by aggregation of immature capsids and some tegument proteins of herpes simplex virus 1
38. Genetic and phenotypic characterization of mutants in four essential genes that map to the left half of HSV-1 UL DNA
39. Identification of novel herpes simplex virus replicative intermediates by field inversion gel electrophoresis: Implication for viral DNA amplification strategies